ABCL
Abcellera Biologics Inc
13.90$
-4.7%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | +9.3% | +4,181.1% | +31.1% | +16.9% | -3.4% | -8.6% | -0.3% | |
| – | -16.6% | +6,334.5% | +14.3% | +10.3% | -15.0% | -13.8% | -3.1% | |
| – | -27.7% | +7,766.0% | -19.9% | -18.8% | -65.5% | +17.3% | -17.8% | |
| – | -27.7% | +7,766.0% | +21.7% | +22.6% | -14.2% | -17.7% | -14.7% | |
| – | +51.2% | +9,962.5% | -18.2% | -40.9% | -37.7% | +43.1% | +66.5% | |
| – | +16,299,900.0% | +763.8% | +18.8% | -8.4% | -27.7% | -100.0% | – | |
| – | +34.0% | +111.4% | +522.8% | +94.6% | – | – | – | |
| – | – | – | +51.8% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | – | – | +28.9% | -11.4% | -8.4% | -65.0% | -8.9% | |
| – | +33.9% | +1,222.4% | +67.3% | +5.1% | +9.1% | -9.3% | +28.1% | |
| – | +22.7% | +1,210.8% | +16.6% | -2.0% | +0.6% | -35.6% | -16.1% | |
| – | +14.0% | -70.0% | +322.2% | +52.9% | +10.3% | -25.0% | +25.8% | |
| – | +8.3% | +345.3% | +103.9% | -0.6% | +72.0% | +34.7% | -26.6% | |
| – | +49.6% | +61.2% | – | – | – | – | – | |
| – | -11.7% | +8,000.9% | +23.5% | +20.2% | -6.6% | -8.4% | -8.4% | |
| – | – | – | +134.4% | +59.2% | -34.4% | -58.2% | -125.2% | |
| – | +57.4% | +10.7% | +21.0% | -1.1% | -8.2% | +1.8% | +1.5% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.